Lucentis ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

lucentis

novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - ophthalmologicals - Луцентис prikazan kod odraslih za liječenje неоваскулярной (vlažna) senilne makularne degeneracije (amd)liječenje vida zbog хориоидальной неоваскуляризации (ХНВ)poremećaje vida zbog dijabetes pomagala макулярного edema (ДМО)poremećaje vida zbog макулярного edema sekundarne okluzije ретинальных vena (branch ili središnji glr glr).

Byooviz ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

byooviz

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - ophthalmologicals - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ximluci ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Ranivisio ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Daktarin 20 mg/g oralni gel ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

daktarin 20 mg/g oralni gel

krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - miconazolum - oralni gel - 20 mg/g - urbroj: 1 g oralnog gela sadrži 20 mg mikonazola

Itrac 100 mg tvrde kapsule ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

itrac 100 mg tvrde kapsule

belupo lijekovi i kozmetika d.d., ulica danica 5, koprivnica, hrvatska - itrakonazol - kapsula, tvrda - 100 mg - urbroj: jedna tvrda kapsula sadrži 100 mg itrakonazola

Pulmocis 2 mg set za pripravu radiofarmaceutika ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

pulmocis 2 mg set za pripravu radiofarmaceutika

cis bio international, rn 306, bp 32 - saclay, gif-sur-yvette, francuska - makroagregat ljudskog albumina - set za pripravu radiofarmaceutika - 2 mg - urbroj: jedna bočica sadrži 2 mg makroagregata ljudskog albumina (makrosalb)

Makro-Albumon 2,0 mg set za pripravu radiofarmaceutika ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

makro-albumon 2,0 mg set za pripravu radiofarmaceutika

medi-radiopharma ltd, szamos utca 10-12, Érd, mađarska - makroagregat ljudskog albumina - set za pripravu radiofarmaceutika - 2,0 mg - urbroj: jedna bočica sadrži 2,0 mg makroagregata ljudskog albumina (makrosalb)